ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

INDV Indivior Plc

1.435,00
-5,00 (-0,35%)
03 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Indivior Plc INDV Londres Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-5,00 -0,35% 1.435,00 12:35:08
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1.440,00 1.437,00 1.474,00 1.435,00 1.440,00
mais cotações »
Setor da Empresa
PHARMACEUTICALS & BIOTECHNOLOGY

Notícias Recentes

Data Hora Fonte Título
25/04/202405:23ALNCNewsIndivior shares down despite profit boost on planned shift..
25/04/202403:00PRNUSIndivior Announces Q1 2024 Financial Results
18/03/202411:28ALNCNewsIN BRIEF: Indivior CCO Richard Simkin sells GBP1 million in..
08/03/202417:04ALNCNewsIN BRIEF: Indivior chief commercial officer sells GBP500,000..
07/03/202409:39ALNCNewsDIRECTOR DEALINGS: Oxford Nanopore Technologies top team..
29/02/202416:10ALNCNewsIndivior says US court draws line on multi-district Suboxone..
22/02/202406:55ALNCNewsTOP NEWS: Indivior swings to profit as eyes primary listing..
20/12/202307:59ALNCNewsIN BRIEF: Indivior agrees settlement with Actavis over..
05/12/202312:38ALNCNewsIndivior and Reckitt land legal boost in UK Suboxone claim
05/12/202312:17DJNIndivior Says UK High Court Strikes Claims Against It and..
17/11/202309:08ALNCNewsUPDATE: Indivior plans up to USD100 million share buyback..
17/11/202306:46ALNCNewsIndivior to keep Scopia's Jerome Lande on board as agreement..
09/11/202307:55ALNCNewsIndivior swings to quarterly loss on costs despite strong..
09/11/202304:05PRNUSIndivior Announces Q3 2023 Financial Results
23/10/202304:40ALNCNewsTOP NEWS: Indivior pays USD385 million to end Suboxone..
11/10/202317:20PRNUSIndivior Enters an Exclusive Licensing Agreement with Alar..
26/09/202315:30PRNUSIndivior Publishes Real World Data Showing SUBLOCADE® May..
21/08/202304:27ALNCNewsIndivior to settle litigation with USD30 million payment to..
21/08/202303:02PRNUSIndivior Reaches Agreement with End Payor Class to Resolve..
01/08/202313:39ALNCNewsTRADING UPDATES: C4X Discovery inks Indivior deal,..
27/07/202307:48ALNCNewsIndivior raises 2023 guidance after strong half-year..
27/07/202303:00PRNUSIndivior Announces Q2/H1 2023 Financial Results
14/06/202314:53PRNUSIndivior Announces Four Abstracts Accepted for Presentation..
12/06/202303:09PRNUSIndivior to Commence Trading on Nasdaq
02/06/202314:18ALNCNewsIndivior settles antitrust claims in US regarding Suboxone..
02/06/202313:18PRNUSIndivior Reaches Agreement with States' Attorneys General..
02/06/202313:11PRNUSIndivior Reaches Agreement with States' Attorneys General..
25/05/202310:30PRNUSIndivior To Participate In Upcoming Investor Conferences
23/05/202313:53PRNUSIndivior PLC Form 20-F Registration Statement for Additional..
23/05/202305:56ALNCNewsIndivior emergency opioid overdose treatment approved by US..
23/05/202304:21DJNIndivior's Overdose-Reversal Nasal Spray Gets FDA Approval
22/05/202320:40PRNUSIndivior Announces U.S. Food and Drug Administration..
10/05/202313:02ALNCNewsDIRECTOR DEALINGS: Indivior division chief sells GBP1.7..

Seu Histórico Recente

Delayed Upgrade Clock